![Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FCOPD.S350167&id=dcop_a_12164092_uf0001_c.jpg)
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
![Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-021-01777-x/MediaObjects/12931_2021_1777_Fig6_HTML.png)
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text
![Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis | Respiratory Research | Full Text Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-020-01540-8/MediaObjects/12931_2020_1540_Fig2_HTML.png)
Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis | Respiratory Research | Full Text
![Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219300145-gr1.jpg)
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
![Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219342254-gr1.jpg)
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
![ARM | Free Full-Text | ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts ARM | Free Full-Text | ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts](https://www.mdpi.com/arm/arm-90-00051/article_deploy/html/images/arm-90-00051-g003.png)
ARM | Free Full-Text | ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts
![First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases | Pulmonary Therapy First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases | Pulmonary Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs41030-021-00179-0/MediaObjects/41030_2021_179_Fig1b_HTML.png)
First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases | Pulmonary Therapy
![Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219818300904-gr1.jpg)
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
![Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future](https://www.peertechzpublications.org/Pulmonology-Respiratory-Care/images/APRC-1-101-g001.gif)
Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología](https://static.elsevier.es/multimedia/03002896/0000005800000010/v2_202302271800/S0300289622003374/v2_202302271800/en/main.assets/gr1.jpeg)
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/3-Figure1-1.png)
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
![Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00347-6/MediaObjects/41533_2023_347_Fig1_HTML.png)
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
![Stepwise management of COPD: What is next after bronchodilation? - Marc Miravitlles, Kazuto Matsunaga, Michael Dreher, 2023 Stepwise management of COPD: What is next after bronchodilation? - Marc Miravitlles, Kazuto Matsunaga, Michael Dreher, 2023](https://journals.sagepub.com/cms/10.1177/17534666231208630/asset/images/large/10.1177_17534666231208630-fig1.jpeg)
Stepwise management of COPD: What is next after bronchodilation? - Marc Miravitlles, Kazuto Matsunaga, Michael Dreher, 2023
![BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone](https://hardoctor.files.wordpress.com/2023/04/bpco-rischio-di-eventi-cardiovascolari-e-terapia-combinata.png)
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png)